ArticleEuropean journal of human genetics : EJHG2025
Towards a patient-centred classification of genetic disease severity.
Article in European journal of human genetics : EJHG, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Outcomes of the national premarital genetic screening program for cystic fibrosis, homocystinuria, and spinal muscular atrophy in Qatar.Human genomics · 2026Article
- Insights in genetics: from molecular mechanisms to patient perspectives.European journal of human genetics : EJHG · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
The concept of disease severity is encountered in numerous clinical situations, especially with genetic disorders. However, there is still no standardized method for defining severity. This study aimed to establish a patient-centred approach for classifying genetic disease characteristics into severity groups, with a focus on the perspectives of expectant parents. Additionally, we conducted a comparative analysis between classifications based on expectant parents' perspectives and those based on healthcare professionals. A questionnaire was administered to 320 expectant women and their partners participating in prenatal classes. The survey gathered ratings for 28 disease characteristics, reflecting their perceived levels of severity. Using these ratings, we constructed two statistical models employing agglomerative hierarchical clustering. The disease characteristics that were most important to our cohort were a shortened lifespan, severe intellectual disability, and severe impaired mobility from childhood or adolescence onwards. Our three-tier expectant parent model revealed a strong association between the severity of disease characteristics and expectant parents' decisions regarding pregnancy termination. On average, 89% of parents would choose to terminate a pregnancy for Tier 1 characteristics, 55% for Tier 2, and 20% for Tier 3. We found a relatively good alignment of our model with the healthcare professional-based classification, with the primary difference being that expectant parents considered a shortened lifespan more important than intellectual disability, compared to professionals. Through this study, we have gained additional insight into the core factors that expectant parents consider essential when assessing the severity of a genetic disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.